Background

Long COVID is a multi-system condition that affects approximately 10% of people following COVID-19 infection.  There are several possible explanations for Long COVID, including persistent viral infection, an autoimmune response, micro-clots, and inflammation. As weight loss is known to have anti-inflammatory benefits, the ReDIRECT study aims to test whether an evidence-based weight loss programme can help alleviate symptoms of Long COVID in people who are overweight.

Recruitment is now complete and we would like to thank all participants for their continued input to the study. The protocol paper is available to view here: The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT)... | NIHR Open Research